Siga Technologies INC Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants
Siga Technologies INC (SIGA) reported Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants of 0 shares for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-10.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants · last filed 2014-03-10
- Siga Technologies INC incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2012-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- Siga Technologies INC incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2012-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- Siga Technologies INC incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2011-09-30 was 1.18M shares.
- Siga Technologies INC incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2011-06-30 was 3.79M shares.
- Siga Technologies INC incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2013 was 0.00 shares.
- Siga Technologies INC incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2012 was 0.00 shares, a 100.00% decline from fiscal 2011.
- Siga Technologies INC incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2011 was 3.13M shares.
- Siga Technologies INC incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2010 was 0.00 shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 3 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 6 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 9 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 12 month |
|---|---|---|---|---|
| 2013-12-31 | 0.00 shares 10-K · filed 2014-03-10 | |||
| 2012-12-31 | 0.00 shares 10-K · filed 2014-03-10 | |||
| 2012-09-30 | 0.00 shares 10-Q · filed 2012-11-05 | 0.00 shares 10-Q · filed 2012-11-05 | ||
| 2012-06-30 | 0.00 shares 10-Q · filed 2012-08-06 | 0.00 shares 10-Q · filed 2012-08-06 | ||
| 2011-12-31 | 3.13M shares 10-K · filed 2014-03-10 | |||
| 2011-09-30 | 1.18M shares 10-Q · filed 2012-11-05 | 3.59M shares 10-Q · filed 2012-11-05 | ||
| 2011-06-30 | 3.79M shares 10-Q · filed 2012-08-06 | 4.09M shares 10-Q · filed 2012-08-06 | ||
| 2010-12-31 | 0.00 shares 10-K/A · filed 2013-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |